Le Blois H, Tuffereau C, Blancou J, Artois M, Aubert A, Flamand A
Laboratoire de Genetique des Virus, CNRS, Gif sur Yvette, France.
Vet Microbiol. 1990 Jun;23(1-4):259-66. doi: 10.1016/0378-1135(90)90156-p.
SAG1, a rabies virus strain bearing one mutation which abolishes virulence for adult animals, was constructed from the SADBern strain of rabies virus which has previously been used as live vaccine for oral immunization of foxes. SAG1 also bears an antigenic mutation which serves as an additional marker of the strain. Studies on mice and four species of wild rodents showed that SAG1 is totally avirulent whereas SADBern is still pathogenic after intracerebral, intramuscular or oral inoculation and thus could cause cases of rabies. Trials of oral vaccination performed on foxes with SAG1 indicate that it is as effective as SADBern. The SAG1 strain represents a significant progress in the search for an efficient and safe live rabies for the oral immunization of wild animals.
SAG1是一种狂犬病病毒株,它带有一个使成年动物丧失毒力的突变,该毒株由狂犬病病毒SADBern株构建而成,SADBern株此前曾用作狐狸口服免疫的活疫苗。SAG1还带有一个抗原性突变,可作为该毒株的额外标记。对小鼠和四种野生啮齿动物的研究表明,SAG1完全无毒,而SADBern在脑内、肌肉内或口服接种后仍具有致病性,因此可能导致狂犬病病例。用SAG1对狐狸进行口服疫苗试验表明,其效果与SADBern相同。SAG1毒株在寻找一种高效、安全的用于野生动物口服免疫的狂犬病活疫苗方面取得了重大进展。